This article was originally published in The Tan Sheet
FDA’s Blumberg dies; Hi-tech sales up, income down; Reliv targets U.S. growth; investigation costs slow Omega Protein; AB Biotics launches AB-Dentis worldwide; Liquid Nutrition franchising reaches U.S.; and Ingredion gets fiber approval in Canada.
You may also be interested in...
FDA approves OTC HIV test; Good Herbs disclaimer does not cancel drug claims; American Herbal Pharmacopoeia releases blue cohosh monograph; salmonella triggers Standard Process supplement recall; Kemin, Ball see zeaxanthin partnership bloom; more In Brief.
The US FDA has announced a high-risk class I recall on two makes of coronary dilation catheters made by Abbott Vascular because a manufacturing issue could lead to difficulties deflating the balloon. The catheters have been linked to 13 complaints and one death.
Roche hopes that its investigational drug satralizumab for neuromyelitis optica spectrum disorder will win EU approval in the second half of 2020.